Bayer Gets CHMP Nod for Eylea 8 mg in the EU for 2 Major Eye Diseases

  • BAYRY's Eylea 8 mg gets CHMP nod in EU, promising 6-month dosing for nAMD and DME with strong 3-year efficacy and safety data.